Quality of Life After Early Clot Removal for Acute Iliofemoral Deep Vein Thrombosis

被引:0
|
作者
Bakas, Jay M. [1 ,4 ]
van Montfrans, Catherine [2 ]
Moelker, Adriaan [3 ]
van den Bos, Renate R. [2 ]
Malskat, Wendy S. J. [2 ]
Verhagen, Hence J. M. [1 ]
van Rijn, Marie Josee E. [1 ,2 ]
机构
[1] Erasmus MC, Dept Vasc & Endovasc Surg, Rotterdam, Netherlands
[2] Erasmus MC, Dept Dermatol, Rotterdam, Netherlands
[3] Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands
[4] Erasmus MC, Dept Surg, POB 2040,Na 2123, NL-3000 CA Rotterdam, Netherlands
关键词
Deep vein thrombosis: endovenous treatment; Mental health; Patient reported outcomes; Quality of life; CATHETER-DIRECTED THROMBOLYSIS; POSTTHROMBOTIC SYNDROME; FOLLOW-UP; VALIDATION; DISEASE; QUESTIONNAIRE; GUIDELINES;
D O I
10.1016/j.ejvsvf.2023.12.004
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: To evaluate patient reported outcome measures after early clot removal for acute deep vein thrombosis (DVT), using the Chronic Venous Disease Quality of Life Questionnaire (CIVIQ-20) and the Short Form Health Survey (SF-36). Methods: Cross sectional design. Patients who underwent early clot removal between June 2012 and November 2021 were asked to complete the two questionnaires once. Lower CIVIQ-20 and higher SF-36 scores indicate better quality of life (QoL). Primary endpoints were the median scores. The one sample Wilcoxon signed rank test was used to compare SF-36 physical and mental component summary (PCS and MCS) to the normative and CIVIQ-20 to the minimum. Secondary, non-parametric independent t test or Fisher's exact test examined how age, sex, body mass index, stent placement, re-intervention, and time of questionnaire completion related to QoL. Multivariable linear regression tested whether various variables were associated with QoL. Results: The response rate was 73.5% (n = 39). Median time of questionnaire completion was 1.8 years (interquartile range [IQR] 3.1) after clot removal. The median CIVIQ-20 of 29.0 (IQR 28.0) was slightly higher than the minimum value 20.0 (p < .001). The median PCS (50.5, IQR 16.6) and median MCS (50.2, IQR 14.2) did not differ from the normative of 50.0. However, wide IQRs indicated impairments for a subgroup of patients. None of the tested variables affected QoL except for the finding that re-interventions had a significantly negative impact on the SF-36 MCS (standardised b coefficient of -0.4, p = .030). Conclusion: Overall patient reported outcome measures were satisfactory after early clot removal, but impaired physical and mental functioning levels were present in a subgroup of patients. Re-interventions were found to have a negative impact on mental QoL. This finding was independent of time that had passed between the procedure and questionnaire completion. This study emphasises that mental functioning deserves attention, besides the widely recognised physical consequences after invasive acute iliofemoral DVT treatment. (c) 2024 The Authors. Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). Article history: Received 30 August 2023, Revised 24 November 2023, Accepted 29 December 2023,
引用
收藏
页码:44 / 49
页数:6
相关论文
共 50 条
  • [11] Quality of life in acute deep vein thrombosis and pulmonary embolism
    Hogg, K.
    Kimpton, M.
    Carrier, M.
    Coyle, D.
    Wells, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 82 - 83
  • [12] Quantity of clot lysed after catheter-directed thrombolysis for iliofemoral deep vein thrombosis correlates with postthrombotic morbidity
    Roddy, Sean P.
    JOURNAL OF VASCULAR SURGERY, 2010, 51 (05) : 1318 - 1319
  • [13] Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis
    Vedantham, S
    Vesely, TM
    Sicard, GA
    Brown, D
    Rubin, B
    Sanchez, LA
    Parti, N
    Picus, D
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2004, 15 (06) : 565 - 574
  • [14] Endovascular Management of Acute Iliofemoral Deep Vein Thrombosis: Who Benefits?
    Desai, Kush R.
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2022, 33 (10) : 1171 - 1172
  • [15] DETERMINANTS OF QUALITY OF LIFE AFTER DEEP-VEIN THROMBOSIS
    Locadia, Mirjam
    Oort, Frans J.
    de Haes, Hanneke J.
    Sprangers, Mirjam A.
    QUALITY OF LIFE RESEARCH, 2005, 14 (09) : 2067 - 2067
  • [16] Rivaroxaban or vitamin-K antagonists following early endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis
    Sebastian, Tim
    Hakki, Lawrence O.
    Spirk, David
    Baumann, Frederic A.
    Periard, Daniel
    Banyai, Martin
    Spescha, Rebecca S.
    Kucher, Nils
    Engelberger, Rolf P.
    THROMBOSIS RESEARCH, 2018, 172 : 86 - 93
  • [17] The future of iliofemoral deep vein thrombosis treatment
    Wittens, Cees H. A.
    Black, Stephen A.
    JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2019, 7 (06) : 771 - 772
  • [18] Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis
    Robertson, Lindsay
    McBride, Olivia
    Burdess, Anne
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (11):
  • [19] Treatment of acute iliofemoral deep venous thrombosis: A strategy of thrombus removal
    Comerota, A. J.
    Paolini, D.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2007, 33 (03) : 351 - 360
  • [20] Cessation of anticoagulation therapy following endovascular thrombus removal and stent placement for acute iliofemoral deep vein thrombosis
    Sebastian, Tim
    Engelberger, Rolf P.
    Spirk, David
    Hakki, Lawrence O.
    Baumann, Frederic A.
    Spescha, Rebecca S.
    Kucher, Nils
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2019, 48 (04) : 331 - 339